Search Results 461-470 of 16982 for rbc

1. Study of INCB053914 in Subjects With Advanced Malignancies - Mayo Clinic

   Hemoglobin (g/dL) | < 8.0 | < 8.0 | Subjects unwilling to receive red blood cell transfusions to treat low hemoglobin levels are excluded; Platelets (× 109/L) ...

2. COVID-19: Who's at higher risk of serious symptoms? - Mayo Clinic News Network

   This inherited disorder causes your red blood cells to become hard, sticky and shaped like the letter "C." These deformed red blood cells die early, so ...

3. Phase III Study Of Datopotamab Deruxtecan Versus Docetaxel In Previously Treated TROP2-positive Advanced Non-squamous NSCLC Without AGA - Mayo Clinic

   Haemoglobin ≥ 9.0 g/dL (red blood cell/plasma transfusion is not allowed within 1 week prior to screening assessment). Absolute neutrophil count ≥ 1.5 ...

4. A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495) - Mayo Clinic

   * Criteria must be met without erythropoietin dependency and without packed red blood cell (pRBC) transfusion within last 2 weeks. ** Creatinine clearance ...

5. A Study to Evaluate the Safety and Effectiveness of Metformin and Nelfinavir with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Participation eligibility · Hemoglobin ≥ 8.0 g/dL (No red cell transfusion should have been administered within 4 days of registration); · Absolute neutrophil ...

6. A Study of the Effect, Safety, and Tolerability of LJPC-501 in Patients with Catecholamine-Resistant Hypotension - Mayo Clinic

   ... red blood cells; Active bleeding AND hemoglobin < 7g/dL or any other condition that would contraindicate serial blood sampling; An absolute neutrophil count ...

7. A Study Comparing CAR-T Therapy Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants with Relapsed and Lenalidomide-Refractory Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥ 8 gram per deciliter (g/dL) (without prior RBC transfusion within 7 days before the laboratory test; recombinant human erythropoietin use is ...

8. Oncology (Medical) - Clinical trials

   [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

9. Cardiovascular Medicine - Clinical trials

   The aim of this study is to evaluate the relation of the acute pacing threshold (volts at 'x' pulse width) to the chronic pacing threshold of a ...

10. Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant - Mayo Clinic

    Participation eligibility · Has received a blood transfusion of packed red blood cells (PRBC), other than with leukocyte-poor blood, within the 90-day period ...